help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García, B.
Right arrow Articles by Obregón, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García, B.
Right arrow Articles by Obregón, M. J.
Endocrinology Vol. 138, No. 10 4227-4233
Copyright © 1997 by The Endocrine Society


ARTICLES

Norepinephrine Potentiates the Mitogenic Effect of Growth Factors in Quiescent Brown Preadipocytes: Relationship with Uncoupling Protein Messenger Ribonucleic Acid Expression1

Bibian García and Maria Jesús Obregón

Unidad de Endocrinología Molecular, Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain

Address all correspondence and requests for reprints to: Dr. M. J. Obregón, Instituto Investigaciones Biomédicas. Consejo Superior de Investigaciones Científicas, Arturo Duperier 4, 28029 Madrid, Spain. E-mail: mjobregon{at}biomed.iib.uam.es


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Rat brown preadipocytes cultured in low serum conditions increase DNA synthesis and proliferate in response to serum and a variety of growth factors and hormones. Epidermal growth factor, platelet-derived growth factor, and acidic and basic fibroblast growth factors stimulate DNA synthesis in a dose-dependent manner and induce at least a 5-fold increase in [3H]thymidine incorporation after 40 h of exposure. The physiological activator of brown adipose tissue, norepinephrine, has a low mitogenic effect per se, but increases DNA synthesis stimulation exerted by serum, epidermal growth factor, basic fibroblast growth factor, and the neuropeptide vasopressin. The addition of vasopressin plus norepinephrine greatly potentiates the mitogenic effect of growth factors to levels comparable to the effect of 10% serum. Preadipocytes cultured in the presence of these mitogen combinations (growth factor, vasopressin, and norepinephrine) express a differentiation marker, the uncoupling protein.

Thus, our results show 1) that a variety of growth factors and hormones induce DNA synthesis in a synergistic fashion in brown preadipocytes in primary culture; and 2) there is evidence for a role of norepinephrine in the regulation of brown adipocyte proliferation, potentiating the action of serum and mitogens, besides its role in uncoupling protein messenger RNA expression.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
BROWN adipose tissue (BAT) activation under physiological situations, such as cold exposure or overeating, results in an increase in the thermogenic capacity of the tissue (1, 2). Facultative thermogenesis is a specific function of BAT, and it is accomplished by the uncoupling protein (UCP), a tissue-specific mitochondrial protein that uncouples oxidative phosphorylation, dissipating as heat the energy that would otherwise be stored as ATP (3). The activation process implies the acquirement of a complete capacity for thermogenesis and involves both cell proliferation of brown adipose precursor cells and promotion of cell differentiation and thermogenesis (4, 5, 6, 7). The tissue is under the control of the sympathetic nervous system, acting via direct noradrenergic innervation of brown adipocytes.

Concerning the proliferation process, several studies have shown that norepinephrine (NE) released from the sympathetic nerve endings is the main mediator of the proliferative stimulus in BAT activation (5, 6, 7). NE also stimulates the proliferation of brown fat cells in primary cultures, but the presence of serum is needed for its mitogenic effect (8). In general, the proliferation of normal cells is stimulated by a variety of ligands (hormones and growth factors) that, in general, seem to act in a combinatorial fashion to induce a full mitogenic response. However, little is known about the factors that control the growth of brown preadipocytes. Insulin-like growth factor I (IGF-I) seems to be an important mitogen for fetal brown adipocytes (9), and recently, transforming growth factor-ß1 has been reported to act as a potent mitogen in the same culture system (10). It has also been shown that brown adipocytes produce basic fibroblast growth factor (bFGF), which may contribute to the enlargement of the tissue (11), and that NE increases bFGF messenger RNA (mRNA) levels (12). It appears, therefore, that NE released from sympathetic nerves represents the initial stimulus in a chain of metabolic events that leads to increased proliferation of precursor cells, but there is no further evidence of other growth factors and hormones that stimulate DNA synthesis in brown fat cells in primary culture being needed for the mitogenic effect of NE.

In this study we have developed a cell culture system of quiescent brown preadipocytes that allows study of growth factors and hormones that may stimulate DNA synthesis in rat brown adipocytes and of the role of NE in the regulation of cell proliferation. We also tested whether the mitogenic stimulus affects the ability of those cells to express the UCP mRNA, which is used as a marker of its thermogenic capacity.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
DMEM was obtained from Life Technologies (Uxbridge, UK). Newborn calf serum (NCS) was obtained from Flow Laboratories (Paisley, Scotland). Antibiotics were purchased from a local pharmacy. BSA (in solution at 22%, pH 7.2) was obtained from Ortho Diagnostic Systems, Johnson & Johnson Co. (Raritan, NJ). Collagenase, bovine insulin, ascorbic acid, guanidinium HCl, 3-N-morpholino-propanesulfonic acid (MOPS), dithiothreitol, NE, and vasopressin were obtained from Sigma Chemcial Co. (St. Louis, MO). IGF-I, IGF-II, acidic FGF (aFGF), bFGF, epidermal growth factor (EGF), and platelet-derived growth factor (PDGF; B/B homodimer) were purchased from Boehringer Mannheim (Mannheim, Germany). aFGF was used in the presence of 50 µg/ml heparin (final concentration), as recommended for proper biological activity. Radiolabeled [{alpha}-32P]deoxy-CTP (3000 Ci/mmol) and [3H]thymidine were obtained from Amersham International (Aylesbury, UK). Formamide was purchased from Merck (Darmstadt, Germany), and the oligo labeling system was purchased from Pharmacia (Uppsala, Sweden). Nytran membranes for RNA blotting were purchased from Schleicher and Schuell (Dassel, Germany), and the glass-fiber filter mats for thymidine incorporation were obtained from Skatron (Sterling, VA) or Wallac Oy (Turku, Finland). All other chemicals were reagent or molecular biology grade.

Cell isolation and culture
Brown fat precursor cells were isolated from the interscapular brown adipose tissue of 20-day-old rats as described by Néchad et al. (13), except that the hypoosmotic shock was not performed. The process involves collagenase digestion, separation of mature adipocytes by flotation, and subsequent filtration through 25-µm silk filters, and precursor cells were obtained by centrifugation. The precursor cells obtained from each animal were divided into two culture flasks (25 cm2; Nunclon, Nunc, Roskilde, Denmark), each containing 5 ml culture medium consisting of DMEM supplemented with 3.5 nM insulin, 10 mM HEPES, 50 IU penicillin/ml, 50 µg streptomycin/ml, 15 µM sodium ascorbate (culture medium), and 10% NCS. The cells were grown at 37 C in an atmosphere of 5% CO2 in air with 95% humidity. Cells were washed on day 1 (2000 cells/cm2), and culture medium was changed every second day.

For proliferation assays, preconfluent cells (days 2–3) were subcultured in 24-multiwell tissue culture plates (Falcon, Becton Dickinson Labware, Lincoln Park, NJ) at a density of 8000 cells/cm2, using 1 ml culture medium supplemented with 10% NCS. After 6 h, the cells were rinsed twice with medium and maintained for 48 h in culture medium supplemented with 2% NCS (time zero). Study of the cell cycle at time zero using cytofluorometric analysis revealed that 95% of cells were in the G0/G1 phase (quiescent cells). This time was the starting point for mitogenic stimulation. Those cells, subcultured at low density, keep the ability to express UCP mRNA (our unpublished results).

For RNA analysis, preconfluent cells (day 3) were used. After being washed and maintained for 48 h in medium supplemented with 2% NCS, quiescent cells were stimulated by the addition of various growth factors and hormones. After 48 h in culture, 10 nM T3 was added, and the RNA isolation was performed 16 h later, with a 4-h pretreatment with 10 µM NE before RNA isolation.

Proliferation assays
Growth factors, hormones, or serum were added to the cells at time zero at the concentrations indicated in each experiment. Cell number was determined essentially as previously described (14). Briefly, after 40 h of treatment, the culture medium was discarded, and the cells were fixed by adding 1% glutaraldehyde in PBS at room temperature for 10 min and thereafter stained with 0.1% crystal violet solution in deionized water for 30 min. After washing with a continuous slow stream of deionized water, plates were allowed to air dry, and the remaining dye was solubilized into a suitable volume of 10% acetic acid solution. Quantification of the cell-absorbed dye was carried out by determining the optical density at 590 nm by spectrophotometry. For [3H]thymidine incorporation assays, quiescent cells were stimulated with mitogenic agents at time zero in the presence of [3H]thymidine (1 µCi/ml). After 40 h of exposure, the medium was discarded, and the cells were removed from the plate using a trypsin-EDTA solution. Thereafter, the contents of each well were harvested onto glass-fiber filters using a Skatron cell harvester (Skatron Instruments, Lier, Norway), and the radioactivity incorporated into DNA was determined using a ß-scintillation counter. Alternatively, a cell harvester from Inotech (Dottikon, Switzerland) or a MicroBeta from Wallac Oy was used in these studies.

Flow cytometry analysis
One million cells were centrifuged, suspended in 300 µl ice-cold PBS, and fixed with 900 µl ice-cold ethanol, added dropwise with continuous vortexing. After two washes with PBS, the cells were suspended in 850 µl PBS containing 5 µg ribonuclease/ml and incubated for 30 min at room temperature. The cells were then stained by adding 125 µl propidium iodide solution (50 µg propidium iodide/ml in 50 mM sodium citrate, pH 7.2, and 0.1% Triton X-100) and analyzed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA) using the CellQuest software from Becton Dickinson Immunocytometry Systems (Mansfield, MA).

RNA analysis
At the end of the experiments, the cells were dissolved in 1 ml hot guanidine-HCl extraction buffer, and RNA was isolated after ethanol precipitation as previously described (15). The RNA concentration was determined by measuring the optical density at 260 nm, and the ratio 260 nm/280 nm was always around 2.0. Samples of total RNA (20 µg) were electrophoresed in 1% agarose gels containing 2.2 M formaldehyde. Methylene blue staining of the gels revealed the presence of equal amounts of RNA in each lane. RNA was blotted into nylon filters (Nytran, NY13). Hybridization and washing were carried out as previously described, using a rat UCP complementary DNA as probe (16) labeled by random oligo priming.

Statistics
The mean values (±SE) reported were obtained from at least three different culture flasks or wells. All experiments presented were repeated at least three times. When not visible in the figures, the SE was smaller than the size of the symbols. One-way ANOVA was applied using SSPS software (SSPS, Chicago, IL). Statistically significant differences between mean values of different groups were then identified by the least significant difference method. All calculations were performed as described by Snedecor and Cochran (17).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Brown fat precursor cells obtained from brown adipose tissue are able to grow and proliferate in culture in the presence of serum. These cells express UCP mRNA when stimulated adrenergically in the presence of T3. For growth stimulation assays we used cells in the proliferative phase, subcultured at a low density. These subcultured cells keep the ability to express UCP mRNA.

Stimulation of DNA synthesis by serum and growth factors
Brown fat cells arrested in the G0/G1 phase of cell cycle can reenter the S phase in response to serum or a variety of growth factors and hormones. Several mitogens were tested for the ability to stimulate DNA synthesis in quiescent brown preadipocytes. As expected for primary cell cultures, none of them induced full mitogenic activation.

When quiescent cultures were stimulated with 10% serum for 40 h, a substantial stimulation of DNA synthesis was obtained (27-fold increase) compared with that in untreated cells (Fig. 1Go). The physiological activator of BAT, NE, when added alone induced a small increase (3.86-fold) in thymidine incorporation at a concentration of 1 µM. The neuropeptide vasopressin added at 20 nM produced a 5.5-fold increase in stimulation of DNA synthesis. Within the group of polypeptide growth factors that bind and activate tyrosine kinase receptors, we found that aFGF, bFGF, PDGF, and EGF stimulate DNA synthesis at concentrations between 1–10 ng/ml. Although PDGF has been shown to be a potent mitogen for many cells types, such as fibroblast Swiss 3T3, in our cells, when added at 10 ng/ml, it only produced a 5-fold increase in thymidine incorporation compared with that in untreated cells. EGF added at 5 ng/ml to cells produced a similar increase in DNA synthesis. We found that aFGF and bFGF are potent mitogens for brown preadipocytes. At 1 ng/ml, aFGF induced an 11-fold increase in thymidine incorporation in the presence of heparin, which is a prerequisite for its biological action. bFGF added at 10 ng/ml had a smaller effect, but it did not require the presence of heparin to exert its mitogenic stimulation (data not shown). By contrast, IGF-I had no effect on thymidine incorporation.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 1. Stimulation of [3H]thymidine incorporation by serum, growth factors, and hormones in cultured brown preadipocytes. Quiescent brown preadipocytes were exposed for 40 h to 10% NCS, NE (1 µM), vasopressin (20 nM), IGF-I (1 nM), bFGF (10 ng/ml), aFGF (1 ng/ml), PDGF (10 ng/ml), and EGF (5 ng/ml) in the presence of 1 µCi/ml [3H]thymidine. Results are expressed as fold increases relative to values in untreated quiescent cells. Data are the mean ± SE obtained from 2–10 independent experiments, with triplicate wells in each experiment. All increases are significantly different with respect to both quiescent cells and 10% NCS, except for IGF-I.

 
NE potentiates the effect of serum on proliferation and [3H]thymidine incorporation
To test whether NE is able to modulate the proliferative effect of serum on brown preadipocytes, quiescent cultures of these cells were treated with increasing concentrations of NCS in the presence of various concentrations of NE (Fig. 2AGo). As shown, increasing amounts of serum up to 10% NCS led to increased thymidine incorporation. When added at 0.1 or 1 µM, NE caused a shift in the dose-response curve of serum on thymidine incorporation, measured after 40 h of incubation. A synergistic effect was observed between NE and low concentrations of serum, and the stimulation was saturated at 1 µM NE. The growth-promoting activity of NE could also be demonstrated when cell number was measured within the same incubation period (Fig. 2BGo). NE added at 1 and 10 µM was able to increase the proliferative effect of serum, and there was a synergistic effect between NE and the lower concentrations of serum. The concentration range required to promote an increase in cell number was higher than that required for DNA synthesis stimulation.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 2. Effects of increasing amounts of serum on [3H]thymidine incorporation and cell number. A, Quiescent brown preadipocytes were treated for 40 h with increasing amounts of serum (1%, 2%, 3%, 4%, 6%, and 10%) in the absence or presence of 0.1, 1, or 10 µM NE, and DNA synthesis was measured in the presence of 1 µCi/ml [3H]thymidine. Data are the mean ± SE obtained from a representative experiment (triplicate wells) performed several times. B, Different concentrations of serum (0.5%, 1%, 5%, and 10%) were added to quiescent brown adipocytes in the presence or absence of 1 or 10 µM NE. After 40 h of incubation, cell number was determined. Data are the mean ± SE from three different culture wells.

 
Effect of NE on the stimulation of DNA synthesis by growth factors
As shown above, NE added alone to cell cultures did not have a great effect on DNA synthesis stimulation, but it did potentiate the stimulatory effect of serum. Therefore, we tested the ability of NE to modulate the effect of those growth factors that we found to be mitogenic for brown preadipocytes. Figure 3Go shows dose-response curves using different mitogens in the absence or presence of 1 µM NE. All of the mitogens stimulated DNA synthesis in a dose-dependent manner, although at different concentration ranges. We found that bFGF, EGF, and PDGF stimulated DNA synthesis at concentrations ranging between 1–10 ng/ml, and aFGF stimulated DNA synthesis at concentrations between 0.1–1 ng/ml. Vasopressin concentrations between 1–10 nM stimulated DNA synthesis, which was markedly potentiated by the addition of NE at either low or high concentrations of vasopressin, reaching an 8-fold increase at 20 nM vasopressin.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 3. Dose-dependent stimulation of [3H]thymidine incorporation by growth factors. Quiescent cultures were exposed for 40 h to different doses of EGF, PDGF, aFGF, bFGF, and vasopressin in the absence or presence of 1 µM NE, and DNA synthesis was measured in the presence of 1 µCi/ml [3H]thymidine. Results are expressed as fold increases relative to values in untreated cells. Data are the mean ± SE of three different culture wells from a representative experiment repeated two to four times depending on the growth factor tested.

 
NE also potentiated the stimulation of DNA synthesis elicited by bFGF and EGF. As for the neuropeptide vasopressin, NE increased the maximal response promoted by both growth factors. In fact, a synergistic effect was observed between the hormone and high concentrations of bFGF. However, potentiation of the EGF response by NE was higher at low concentrations of EGF (0.1–1 ng/ml). The stimulatory effect of PDGF was slightly increased by the addition of NE at low concentrations of the growth factor, and there was no potentiation at higher doses of PDGF. aFGF is the most potent mitogen tested for brown preadipocytes, but the addition of NE did not affect the stimulatory effect of this growth factor.

Stimulation of DNA synthesis and proliferation by different combinations of mitogens
Given that in most culture systems the addition of more than one growth factor is required for complete mitogenic activation, we studied whether vasopressin was able to affect the stimulation of DNA synthesis elicited by mitogenic concentrations of polypeptide growth factors.

As shown in Fig. 4Go, the addition of 20 nM vasopressin to the cell culture enhanced the mitogenic effect elicited by the four polypeptide growth factors. Thymidine incorporation in response to EGF increased from 5- to 17-fold when vasopressin was added. The potentiation of PDGF and bFGF by vasopressin was low, but the effect on DNA synthesis stimulation elicited by aFGF was greatly enhanced. Given that NE potentiates the growth-promoting effect of vasopressin, we tested the effect of the addition of NE to the combination of polypeptide growth factors and vasopressin. A marked potentiation of thymidine incorporation was observed when 1 µM NE was added for all growth factors combinations. In all cases, thymidine uptake was comparable to that obtained in the presence of 10% serum; the most mitogenic combinations were those including the presence of EGF or aFGF. Cell number was measured after the same incubation period to monitor whether these mitogenic combinations stimulate proliferation. Addition of the mitogenic combinations (polypeptide growth factor plus vasopressin plus NE) resulted in a duplication of cell number, as shown in Table 1Go. The presence of 10% serum increased cell number from 19,000 to 112,000, corresponding to nearly three cycles of cell division.



View larger version (37K):
[in this window]
[in a new window]
 
Figure 4. Effects of vasopressin and NE addition on [3H]thymidine incorporation induced by growth factors. Quiescent brown adipocytes were exposed to the various growth factors, EGF (5 ng/ml), PDGF (10 ng/ml), aFGF (1 ng/ml), and bFGF (5 ng/ml), in the absence or presence of 20 nM vasopressin or 20 nM vasopressin plus 1 µM NE. [3H]Thymidine incorporation (1 µCi/ml) was measured after 40 h of incubation in the presence of [3H]thymidine and mitogens. Results are expressed as fold increases relative to values in untreated cells. Data are the mean ± SE from three different culture wells from a representative experiment performed several times.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Stimulation of cell proliferation in response to growth factors, vasopressin, and NE

 
Effect of mitogenic combinations on UCP mRNA expression by brown adipocytes
To test the thermogenic capacity of cell cultures proliferating in the presence of the different mitogenic combinations, UCP mRNA expression was analyzed as an specific differentiation marker of brown adipocytes. For this purpose, quiescent cell cultures were treated with the different mitogen combinations that led to a significant increase in cell proliferation (polypeptide growth factor plus vasopressin plus NE). After 48 h in the presence of mitogens, half of the flasks received 10 nM T3 and 10 µM NE during the last 16 and 4 h, respectively, before RNA isolation. Figure 5Go shows that, as described extensively, brown adipocytes express UCP mRNA when stimulated adrenergically in the presence of T3. The 16-h treatment with T3 was sufficient to obtain a detectable signal in the cells exposed chronically to NE (data not shown), but the addition of NE 4 h before RNA isolation strongly increased UCP mRNA levels. As shown, the expression level attained varied depending on the mitogen combinations used. In the presence of aFGF, the expression of the transcript was greatly enhanced compared with that elicited by the other mitogens, including serum. Thus, aFGF could play a role not only in stimulation of DNA synthesis, but also in acquisition of the differentiated state.



View larger version (72K):
[in this window]
[in a new window]
 
Figure 5. UCP mRNA expression in brown preadipocyte primary cultures subject to different growth stimuli. Quiescent cell cultures were treated for 72 h with various growth factors, EGF (5 ng/ml), PDGF (10 ng/ml), aFGF (1 ng/ml), and bFGF (5 ng/ml), plus vasopressin (20 nM) and NE (1 µM). Before RNA isolation, half of the flasks received 10 nM T3 for 16 h and 10 µM NE for 4 h [as shown in the even (+) lanes]. The figure shows data from a representative experiment repeated more than five times.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The main proliferative activity of brown fat tissue occurs mainly during the perinatal period (18) and with cold exposure (5). The initial development of brown fat tissue can be prenatal, perinatal, or postnatal depending on the species (19), and in the rat takes place during the last days of fetal life, when the tissue is recruited to face the cold experienced after birth (20). Little is known about the hormones that control proliferation during this period, although IGF-I and transforming growth factor-ß1 have been described as potent mitogens, using in vitro cultured fetal preadipocytes (9, 10). During this period, DNA increases, and the tissue acquires a high thermogenic capacity to respond to cold exposure (19, 20).

Besides fetal life, cold exposure is another situation in which increased thermogenesis is required. In this situation, adrenergic stimulation increases the thermogenic capacity of BAT, and this involves an increase in the number of brown fat cells as well as an increase in the thermogenic capacity of each cell, which is accounted for by an increase in the UCP content of the tissue (1, 2, 3, 4).

In the present study we describe for the first time a culture system of quiescent brown preadipocytes obtained from newborn rats that allows study of the proliferative capacity of several hormones and growth factors that might contribute to BAT hyperplasia. The cell density we used is 5–15 times lower than that in previous reports (8,000 vs. 125,000 cells/cm2) (8, 9), allowing a wider margin for study of the proliferative activity than in previous reports.

Using this system, we show that aFGF and bFGF are potent inducers of DNA synthesis in brown fat cells; the former is the most potent growth factor tested. Both of them are potent mitogens for a variety of normal mammalian cell types from mesoderm and neuroectoderm origin and are also potent mitogens for a large number of established cell lines. They are also capable of inducing angiogenesis in vivo (21). Recently, bFGF has been shown to be involved in BAT enlargement induced by cold exposure (11), and NE considerably increased the levels of bFGF mRNA in brown adipocyte primary cultures (12). bFGF is also produced by endothelial cells, an important event for BAT growth because during BAT activation there is a large increase in endothelial cell proliferation (5) due to the need for de novo capillary formation. Our results are in accordance with these data, as we found that bFGF is a true mitogen for rat brown preadipocytes in primary cultures, and its stimulatory effect on DNA synthesis is potentiated by the addition of NE. Furthermore, aFGF is the most potent growth factor tested in our cell culture system. Besides its mitogenic and angiogenic actions, some studies suggest that both bFGF and specially aFGF participate in the central regulation of food intake (22, 23). In fact, the concentration of aFGF in rat cerebrospinal fluid markedly increases after the start of feeding, and food intake is suppressed by the infusion of aFGF (22). BAT is important for the maintenance of energy balance, as transgenic mice in which the amount of UCP is decreased develop obesity (24). Also, chronic stimulation by long term overfeeding with a palatable "cafeteria diet" causes BAT hypertrophy (2). Thus, many hormones and peptides involved in the control of food intake may be important in BAT activation.

Another hormone related to food intake control is vasopressin. It is produced in the ventromedial nucleus of the hypothalamus, which is known to be the satiety control area, and it has anorectic effects when administered centrally (25). Vasopressin, which stimulates DNA synthesis in Swiss 3T3 cells (26), is produced by small cell lung carcinoma and has been shown to stimulate the clonal growth of small cell lung carcinoma cells in soft agar (27). In our system, vasopressin stimulation of DNA synthesis is low, but increases up to 8-fold after the addition of NE.

PDGF and EGF are polypeptide growth factors of wide spectrum. None of them stimulates DNA synthesis to a great extent, as shown previously for fetal brown adipocytes (9). In that report, EGF required the presence of neuropeptides such as vasopressin and bombesin to induce a full mitogenic response. Our results show that EGF in the presence of vasopressin and NE induces a substantial increase in both DNA synthesis and cell proliferation. However, the polypeptide growth factor IGF-I does not exert a significant stimulation of DNA synthesis in our cells despite the fact that it is a complete mitogen for fetal brown adipocytes (9, 28). Also, NE addition does not alter its effect on thymidine incorporation (data not shown). It might be possible that the growth factors that lead to cell proliferation during fetal development of BAT are different from those involved in the enlargement of the tissue during the neonatal and adult periods as well as with cold exposure.

When BAT activation takes place in the rat in response to cold acclimation or after the intake of a hypercaloric diet, hyperplasia of the tissue is seen, mainly due to the increased proliferation of brown fat precursor cells and endothelial cells (5). This effect is mediated through sympathetic innervation (29). NE has been shown to be necessary for brown fat recruitment (7, 29), and various studies, including ours, show that it directly activates the proliferation of brown fat cells (7, 8, 12), but it seems to require the presence of unknown growth factors and hormones present in serum that contribute to the increased proliferation observed (8). Our results show that NE per se does not greatly stimulate DNA synthesis, but does potentiate the growth-promoting activity of serum and growth factors on both thymidine incorporation and cell proliferation. These results are consistent with previous reported data (8). Thus, some factors present in serum are required for the NE effect. Our data suggest that bFGF, EGF, and vasopressin could be involved in this stimulatory effect of NE. The growth-promoting activity of aFGF does not increase in the presence of NE, but addition of the combination of vasopressin plus NE produces a substantial increase in DNA synthesis stimulation. Thus, it seem clear that each growth factor tested has a peculiar pattern of potentiation by NE, vasopressin, or their combination.

The acquisition of a total thermogenic capacity also involves an augmented content of UCP. In this context, we tested the ability of cultured cells to express UCP mRNA as an indication of its thermogenic capacity in the presence of the different mitogen combinations. Brown preadipocytes maintained in the continuous presence of polypeptide growth factor, vasopressin, and NE express UCP mRNA when T3 is present. The addition of NE 4 h before RNA isolation increases the amount of the UCP transcripts. Thus, it seems that the presence of NE not only potentiates the stimulatory effect of other mitogens, but also increases the ability of cells to express differentiation markers. NE stimulates both proliferation and differentiation in brown fat cells, and this effect seems to be caused by an increase in intracellular cAMP levels (6, 7, 8). Canine thyrocytes in primary culture also undergo both proliferation and differentiation when stimulated by TSH (30, 31). On the other hand, the different growth factor combinations exert different effects on UCP mRNA expression. Some growth factors, such as EGF and PDGF, could interfere with the induction of UCP mRNA expression in response to differentiating conditions. Further work is needed to elucidate the role of NE in the stimulation of proliferation and differentiation as well as the effects of the different mitogens on expression of the differentiation marker, UCP.


    Acknowledgments
 
We thank Dr. G. Giménez-Gallego for the gift of aFGF for some experiments, and Dr. D. Ricquier (Paris, France) for providing us with the rat UCP complementary DNA. We also thank Dr. J. Martín-Nieto for help in correcting the manuscript.


    Footnotes
 
1 This work was supported by Research Grants PB 92–0061 from DGICYT and FISS 94/0274 from the Fondo de Investigaciones Sanitarias (Spain). Presented in part in the 24th Meeting of the Federation of European Biochemical Societies, Barcelona, Spain, 1996. Back

Received May 1, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bouillaud F, Ricquier D, Mory G, Thibault J 1984 Increased level of mRNA for the uncoupling protein in brown adipose tissue of rats during thermogenesis induced by cold exposure or norepinephrine infusion. J Biol Chem 259:11583–11586[Abstract/Free Full Text]
  2. Rothwell NJ, Stock MJ 1986 Brown adipose tissue and diet-induced thermogenesis. In: Trayhurn P, Nicholls DG (eds) Brown Adipose Tissue. Arnold, Baltimore, pp 269–298
  3. Nicholls DG, Cunningham SA, Rial E 1986 The bioenergetic mechanisms of brown adipose tissue thermogenesis. In: Trayhurn P, Nicholls DG (eds) Brown Adipose Tissue. Arnold, Baltimore, pp 52–85
  4. Nedergaard J, Cannon B 1985 (3H)GDP binding and thermogenin amount in brown adipose tissue mitochondria from cold-exposed rats. Am J Physiol 248:C365–C371
  5. Bukowiecki LJ, Géloën A, Collet AJ 1986 Proliferation and differentiation of brown adipocytes from interstitial cells during cold acclimation. Am J Physiol 250:C880–C887
  6. Géloën A, Collet AJ, Guay G, Bukowiecki LJ 1988 ß-Adrenergic stimulation of brown adipocyte proliferation. Am J Physiol 254:C175–C182
  7. Rehnmark S, Nedergaard J 1989 DNA synthesis in mouse brown adipose tissue is under ß-adrenergic control. Exp Cell Res 180:574–579[CrossRef][Medline]
  8. Bronnikov G, Houstek J, Nedergaard J 1992 ß-Adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture: mediation via ß1 but not ß3 adrenoceptors. J Biol Chem 267:2006–2013[Abstract/Free Full Text]
  9. Valverde A, Benito M, Lorenzo M 1991 Proliferation of fetal brown adipocyte primary cultures: relationship with the genetic expression of glucose-6-phosphate dehydrogenase. Exp Cell Res 194:232–237[CrossRef][Medline]
  10. Teruel T, Valverde AM, Benito M, Lorenzo M 1996 Transforming growth factor ß1 induces mitogenesis in fetal rat brown adipocytes. J Cell Physiol 166:577–584[CrossRef][Medline]
  11. Yamashita H, Sato N, Kizaki T, Oh-ishi S, Nagasawa J, Ohno H 1994 Basic fibroblast growth factor (bFGF) contributes to the enlargement of brown adipose tissue during cold acclimation. Pflugers Arch 428:352–356[CrossRef][Medline]
  12. Yamashita H, Sato N, Kizaki T, Oh-ishi S, Segawa M, Saitoh D, Ohira Y, Ohno H 1995 Norepinephrine stimulates the expression of fibroblast growth factor 2 in rat brown adipocyte primary culture. Cell Growth Differ 6:1457–1462[Abstract]
  13. Néchad M, Kuusela P, Carneheim C, Björntorp P, Nedergaard J, Cannon B 1983 Developmental of brown fat cells in monolayer culture. I. Morphological and biochemical distinction from white fat cells in culture. Exp Cell Res 149:105–118[CrossRef][Medline]
  14. Guillies RJ, Didier N, Denton M 1986 Determination of cell number in monolayer cultures. Anal Biochem 159:109–113[CrossRef][Medline]
  15. Herron D, Néchad M, Rehnmark S, Nelson BD, Nedergaard J, Cannon B 1989 Effects of cholera toxin on gene expression in brown preadipocytes differentiating in culture. Am J Physiol 257:C920–C925
  16. Bouillaud F, Weisenbach J, Ricquier D 1986 Complete cDNA-derived amino acid sequence of rat brown fat uncoupling protein. J Biol Chem 261:1487–1490[Abstract/Free Full Text]
  17. Snedecor GW, Cochran WG 1980 Statistical Methods, ed 7. Iowa State University Press, Ames
  18. Barnard T 1969 The ultrastructural differentiation of brown adipose tissue in the rat. J Ultrastruct Res 29:311–332[CrossRef][Medline]
  19. Nedergaard J, Connolly E, Cannon B 1986 Brown adipose tissue in the mammalian neonate. In: Trayhurn P, Nicholls DG (eds) Brown Adipose Tissue. Arnold, London, pp 152–213
  20. Obreg-n MJ, Jacobsson A, Kirchgessner T, Schotz MC, Cannon B, Nedergaard J 1989 Postnatal recruitment of brown adipose tissue is induced by the cold stress experienced by the pups. An analysis of mRNA levels for thermogenin and lipoprotein lipase. Biochem J 259:341–346[Medline]
  21. Thomas KA, Gimenez-Gallego G 1986 Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci 11:1–4
  22. Oomura Y, Sasaki K, Suzuki K, Muto T, Li A-J, Ogita Z-I, Hanai K, Tooyama I, Kimura H, Yanaihara N 1992 A new brain glucosensor and its physiological significance. Am J Clin Nutr 55:278S–282S
  23. Li A-J, Oomura Y, Hori T, Aou S, Sasaki K, Kimura H, Tooyama I 1996 Fibroblast growth factor receptor-1 in the lateral hypothalamic area regulates food intake. Exp Neurol 137:318–323[CrossRef][Medline]
  24. Lowell BB, Susulic V-S, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS 1993 Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740–742[CrossRef][Medline]
  25. Bray GA 1995 Nutrient intake is regulated by peripheral peptide administration. Obes Res [Suppl 4] 3:569S–572S
  26. Rozengurt E, Legg A, Pettican P 1979 Vasopressin stimulation of mouse 3T3 cell growth. Proc Natl Acad Sci USA 76:1284–1287[Abstract/Free Full Text]
  27. Sethi T, Langdon S, Smyth J, Rozengurt E 1992 Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res 52:2737s–2742s
  28. Lorenzo M, Valverde AM, Teruel T, Benito M 1993 IGF-I is a mitogen involved in differentiation-related gene expression in fetal rat brown adipocytes. J Cell Biol 123:1567–1575[Abstract/Free Full Text]
  29. Géloën A, Collet AJ, Bukowiecki LJ 1992 Role of the sympathetic innervation in brown adipocyte proliferation. Am J Physiol 263:R1176–R1181
  30. Dumont JE, Jauniaux JC, Roger PP 1989 The cAMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67–71[CrossRef][Medline]
  31. Roger PP, Reuse S, Maenhaut C, Dumont JE 1995 Multiple facets of the modulation of growth by cAMP. Vitam Horm 51:59–191[Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
A. Hernandez, B. Garcia, and M.-J. Obregon
Gene Expression from the Imprinted Dio3 Locus Is Associated with Cell Proliferation of Cultured Brown Adipocytes
Endocrinology, August 1, 2007; 148(8): 3968 - 3976.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. CANNON and J. NEDERGAARD
Brown Adipose Tissue: Function and Physiological Significance
Physiol Rev, January 1, 2004; 84(1): 277 - 359.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Hernandez, D. L. St. Germain, and M. J. Obregon
Transcriptional Activation of Type III Inner Ring Deiodinase by Growth Factors in Cultured Rat Brown Adipocytes
Endocrinology, February 1, 1998; 139(2): 634 - 639.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. Garcia and M.-J. Obregon
Growth factor regulation of uncoupling protein-1 mRNA expression in brown adipocytes
Am J Physiol Cell Physiol, January 1, 2002; 282(1): C105 - C112.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García, B.
Right arrow Articles by Obregón, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García, B.
Right arrow Articles by Obregón, M. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals